Patterns of steroid use in patients with established rheumatoid arthritis commencing treatment with biologic or targeted synthetic DMARDs
Despite the introduction of b/tsDMARDs, steroid use in this cohort continued over the first year of follow-up, particularly in patients with more severe RA. Together with previous data, this further highlights the need for future research and trials to better understand the right course of steroid administration to maximize efficacy and limit adverse side effects.
Authors
- Darren Plant (ORCID: https://orcid.org/0000-0003-1395-9344)
- Anne C Barton (ORCID: https://orcid.org/0000-0003-3316-2527)
- A. G. Wilson
- Kimme Leanne Hyrich (ORCID: https://orcid.org/0000-0001-8242-9262)
- John D. Isaacs (ORCID: https://orcid.org/0000-0002-6103-7056)
- Michael A. Stadler (ORCID: https://orcid.org/0000-0003-3689-4256)
- Chuan Fu Yap (ORCID: https://orcid.org/0000-0001-5256-5642)
- James Bluett (ORCID: https://orcid.org/0000-0001-5062-5779)
- Shae Bindra
- Annie Cheung
- Ann Morgan
- Nisha Nair
Institutions
- University College Dublin (IE)
- University of Leeds (GB)
- Leeds Teaching Hospitals NHS Trust (GB)
- University of Manchester (GB)
- Clinical Research Institute (US)
- Arthritis UK (GB)
- NIHR Newcastle Biomedical Research Centre (GB)
- NIHR Manchester Biomedical Research Centre (GB)
- University of Newcastle Australia (AU)
- Newcastle University (GB)
Publication Details
- Journal
- Rheumatology Advances in Practice
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1093/rap/rkaf130
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Research
- Versus Arthritis